Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Building genetic assessments into how we determine prognosis of ALL
Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma
EMMA 2017 meeting in Madrid: what to expect
UKALL60+: identifying the standard of care for elderly patients with ALL